Table 1 Patient characteristics.

From: One year outcomes of intravitreal faricimab for treatment Naïve neovascular AMD and associations with baseline aqueous humor cytokines

 

nAMD

N (eye)

34 (32)

Age, years

75.2 ± 8.48

Sex, male (%)

22 (69)

Axial length, mm

23.71 ± 0.96

BCVA, logMAR

0.479 ± 0.519

CST, µm

311 ± 68.9

CCT, µm

191 ± 103.0

Disease subtype*, [eyes]

14, 4, 6, 10

  1. *Macular neovascularization (MNV) type 1, MNV type 2, MNV type 3, and polypoidal choroidal vasculopathy.
  2. AMD, age-related macular degeneration; BCVA, best corrected visual acuity; CST, central subfield retinal thickness; CCT, central choroidal thickness.
Back to article page